Hashami Leila, Rakhshan Vahid, Karimian Hoda, Moghaddasi Mehdi
Department of Neurology, Rasool Akram Hospital, Iran University of Medical Sciences , Tehran, Iran.
Department of Dental Anatomy and Morphology, Dental Branch, Islamic Azad University , Tehran, Iran.
Neurol Int. 2016 Jun 15;8(2):6310. doi: 10.4081/ni.2016.6310.
Cerebral venous thrombosis (CVT) is a long-term debilitating vascular brain disease with high morbidity and mortality. It may be associated with rise in D-dimer level. The aim of this study was to examine this potential association and identify the critical D-dimer cut-off level corresponding to increase the risk of CVT. This case-control study was conducted on two groups of patients with and without CVT attending the Rasool Akram Hospital (Iran) during 2014 and 2015. D-dimer levels were measured by the rapid sensitive D-dimer assay. Data were analyzed by Spearman's correlation coefficient test, independent-samples t-test, backward-selection multiple linear regression and multiple binary logistic regression analyses. Sensitivity-specificity tests were used to detect D-dimer cut-off for CVT. Differences between the D-dimer levels of the case and control groups were significant (P<0.001). It showed that each level of increase in the number of symptoms could increase the risk of thrombosis occurrence for about 3.5 times. All symptom types except for headache were associated with D-dimer level, while headache has negative association with D-dimer level. D-dimer cut-off point for CVT diagnosis was estimated at 350 ng/mg. We concluded that D-dimer serum level significantly rises in CVT patients. A rounded cut-off point of 350 ng/mg can be used as a diagnostic criterion for CVT prediction.
脑静脉血栓形成(CVT)是一种长期使人衰弱的脑血管疾病,发病率和死亡率都很高。它可能与D - 二聚体水平升高有关。本研究的目的是检验这种潜在关联,并确定与CVT风险增加相对应的关键D - 二聚体临界值。这项病例对照研究于2014年至2015年期间在拉苏勒·阿克拉姆医院(伊朗)对两组有或没有CVT的患者进行。通过快速敏感的D - 二聚体检测法测量D - 二聚体水平。数据通过Spearman相关系数检验、独立样本t检验、向后选择多元线性回归和多元二元逻辑回归分析进行分析。使用敏感性 - 特异性检验来检测CVT的D - 二聚体临界值。病例组和对照组的D - 二聚体水平差异显著(P<0.001)。结果表明,症状数量每增加一级,血栓形成的风险可能增加约3.5倍。除头痛外的所有症状类型均与D - 二聚体水平相关,而头痛与D - 二聚体水平呈负相关。CVT诊断的D - 二聚体临界值估计为350 ng/mg。我们得出结论,CVT患者的血清D - 二聚体水平显著升高。350 ng/mg的整数临界值可作为CVT预测的诊断标准。